Cite
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
MLA
Anani Badje, Mph, et al. “Effect of Isoniazid Preventive Therapy on Risk of Death in West African, HIV-Infected Adults with High CD4 Cell Counts: Long-Term Follow-up of the Temprano ANRS 12136 Trial.” The Lancet Global Health, vol. 5, no. 11, Nov. 2017, pp. e1080–89. EBSCOhost, https://doi.org/10.1016/S2214-109X(17)30372-8.
APA
Anani Badje, M., Raoul Moh, P., Delphine Gabillard, Ms., Calixte Guéhi, P., Mathieu Kabran, P., Jean-Baptiste Ntakpé, M., Jérôme Le Carrou, P., Gérard M Kouame, M., Eric Ouattara, P., Eugène Messou, P., Amani Anzian, M., Albert Minga, P., Joachim Gnokoro, M., Patrice Gouesse, M., Arlette Emieme, P., Thomas-d’Aquin Toni, P., Cyprien Rabe, M., Baba Sidibé, M., Gustave Nzunetu, M., … Xavier Anglaret. (2017). Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. The Lancet Global Health, 5(11), e1080–e1089. https://doi.org/10.1016/S2214-109X(17)30372-8
Chicago
Anani Badje, Mph, PhD Raoul Moh, Msc Delphine Gabillard, PhD Calixte Guéhi, PharmD Mathieu Kabran, Mph Jean-Baptiste Ntakpé, PhD Jérôme Le Carrou, et al. 2017. “Effect of Isoniazid Preventive Therapy on Risk of Death in West African, HIV-Infected Adults with High CD4 Cell Counts: Long-Term Follow-up of the Temprano ANRS 12136 Trial.” The Lancet Global Health 5 (11): e1080–89. doi:10.1016/S2214-109X(17)30372-8.